Thursday, April 25, 2013

XBiotech Enrolls Its First Patient in Highly Anticipated Phase III Pivotal Trial of Xilonix

Read about how XBiotech Enrolls Its First Patient in the Highly Anticipated Phase III Pivotal Trial of Xilonix.

http://bionews-tx.com/news/2013/04/25/xbiotech-enrolls-first-patient-in-phase-iii-pivotal-trial-of-xilonixtm/

No comments:

Post a Comment